Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Improved CRBN ligands make protein degraders more effective and drug-like.

New method measures finasteride in plasma, finds two formulations bioequivalent.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Zinc carbonate nanoparticles are not irritating or absorbed by the skin.

PRP could be a promising treatment for hair loss but needs more research.

Clozapine levels in hair reflect dosage and bind more to pigmented hair.

Drug repurposing finds new uses for existing drugs, saving time and money.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

PRP is more effective than triamcinolone for treating alopecia areata.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

PRP is safer and has a lower relapse rate than TAC for treating alopecia areata.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Topical 4-aminopyridine 5% does not improve hair growth in male pattern baldness.

Sunscreen spray on the scalp may be linked to a type of scarring hair loss.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

The new method improves finasteride's effectiveness for hair loss treatment.